Core Viewpoint - Lin Qingxuan is set to become the first high-end domestic skincare brand listed on the Hong Kong Stock Exchange, following its successful hearing and submission of post-hearing documents [1] Industry Overview - The Chinese cosmetics market is expanding, driven by increased consumer focus on health and appearance, digital transformation in shopping behavior, and a growing interest in healthier, high-quality products. Skincare products hold the largest market share, with the market size projected to grow from RMB 332.9 billion in 2019 to RMB 461.9 billion in 2024, reflecting a compound annual growth rate (CAGR) of 6.8% [1] Company Performance - Lin Qingxuan's total revenue is projected to grow from RMB 691 million in 2022 to RMB 1.21 billion in 2024, achieving a CAGR of 32.3%. In the first half of this year, the company reported revenue of RMB 1.052 billion, a year-on-year increase of 98.3%. The adjusted net profit for the same period rose by 117.4% to RMB 200 million, nearly matching the full-year profit for 2024, indicating strong growth momentum [2] - The market for high-end anti-wrinkle and firming skincare products is expected to increase from RMB 59.4 billion in 2024 to RMB 155.5 billion by 2029, with a CAGR of 21.2%. The overall high-end skincare industry in China is projected to reach RMB 218.5 billion by 2029, with a CAGR of 13.8% from 2024 to 2029 [2] Strategic Positioning - Lin Qingxuan is poised to benefit from its strong R&D capabilities and leading products. The company plans to enhance its product matrix and offer more customized skincare solutions for diverse applications, thereby strengthening brand recognition and leading the high-quality development of domestic beauty brands [3]

Core Viewpoint - Lin Qingxuan, a high-end domestic skincare brand, is facing market skepticism as it attempts a second IPO in Hong Kong after its previous prospectus expired, primarily due to its heavy reliance on a single product, Camellia Oil, which accounts for a significant portion of its revenue [2][5]. Financial Performance - Lin Qingxuan's revenue from 2022 to the first half of 2025 showed a notable increase, with figures of 6.91 billion, 8.05 billion, 12.1 billion, and 10.52 billion respectively. The net profit for the same periods was -0.5931 billion, 0.84518 billion, 1.87 billion, and 1.82 billion, with gross margins of 78%, 81.2%, 82.5%, and 82.4% [4]. Product Dependency - The company's revenue is heavily dependent on its flagship product, Camellia Oil, which generated 4.48 billion in 2024, accounting for 37% of total revenue, and further increased to 45.5% in the first half of 2025, with revenue reaching 4.79 billion. Other product lines, such as creams and lotions, have consistently contributed less than 20% to total sales [5][6]. Marketing vs. R&D Investment - Lin Qingxuan's marketing and promotional expenses have significantly outpaced its research and development (R&D) investments, with total marketing costs reaching 11.21 billion, which is 12.55 times higher than its R&D costs of 8930.1 million during the same period. The marketing expenses accounted for approximately 30% of total revenue [6][7]. Compliance Issues - The company has faced multiple penalties for false advertising, indicating systemic issues in its promotional management. Recent fines include 21,200 for misleading claims about product efficacy, contributing to a negative perception that could impact its IPO process [8][9]. Shareholder Structure - Prior to the IPO, the founder, Sun Laichun, holds 38.21% of the shares directly and approximately 79.27% in total through various entities. External investors include companies like Youngor Fashion and Country Garden Venture Capital [9][10]. Market Position - Lin Qingxuan ranks first among domestic high-end skincare brands in China based on retail sales as of 2024, with a total of 230 SKUs across various product categories [3].

Investment Rating - The report maintains an "Overweight" rating for the retail sector, focusing on companies with strong operational resilience or signs of bottom reversal [6][63]. Core Insights - The focus has shifted from policy catalysts to fundamental performance, with an emphasis on companies demonstrating operational resilience or potential recovery from low points [2][15]. - The retail sector experienced a relatively small decline of -0.21% during the week of December 8-12, 2025, outperforming other consumer-related sectors [1][7]. - The report highlights specific stocks that have shown significant price movements, such as Guai Bao Pet and TCL Electronics, which saw increases due to various catalysts [2][16]. Summary by Sections Market Overview - The retail sector's performance was relatively stable compared to other sectors, with a decline of only -0.21%, ranking 12th among all sectors [1][7]. - The overall market sentiment has shifted towards technology and high-end manufacturing, leading to weaker returns in consumer and cyclical sectors [2][15]. Stock Performance - Notable gainers included Guai Bao Pet, which rose by 2.7%, and TCL Electronics, which increased by 2.5%, attributed to factors such as oversold rebounds and improved performance expectations [2][16]. - Conversely, stocks like Pop Mart faced declines due to disappointing sales during the overseas Black Friday promotions, raising concerns about future growth [2][16]. Future Outlook - The report suggests that investment opportunities may be limited as policy expectations have stabilized, recommending stocks with strong fundamentals and low valuation percentiles [3][17]. - Three main investment themes are proposed: benefiting from holiday travel and tourism, domestic brands with competitive advantages, and durable goods companies likely to benefit from U.S. interest rate cuts [3][17]. Sector News - In the cosmetics sector, sales on major platforms reached 37.64 billion yuan in the first 11 months, with Proya leading in several categories [4][18]. - The home appliance sector saw the launch of a new smart air conditioning factory by Xiaomi, enhancing its production capabilities [4][19]. - The furniture sector is addressing consumer pain points with new commitments from leading companies to ensure quality and service [4][20].

Group 1: Retail and Service Industry Insights - The report highlights a recovery in the hotel and duty-free sectors, suggesting that the hotel prices have gradually increased since the second half of this year, with a recommendation to focus on hotel stocks such as Huazhu Group, Jinjiang Hotels, and ShouLai Hotels [6][12][17] - Duty-free sales are showing signs of bottoming out, with new policies implemented to expand the range of duty-free products and eligible consumers, leading to a significant increase in sales figures [12][15][16] - The report emphasizes the importance of service consumption policies, particularly in the context of the ice and snow economy, silver-haired economy, and sports events, recommending investments in companies like Changbai Mountain and Sanchuan Tourism [26][28][29] Group 2: AI Applications in Various Industries - The report discusses the acceleration of AI applications in the education and human resources sectors, with companies like Keri International and Beijing Renli leveraging AI to enhance recruitment efficiency [39][44] - AI's integration into 3D printing and e-commerce is highlighted, with a focus on companies like Huina Technology and Xiaogoods City, which are expected to benefit from cost reductions through full-chain penetration [6][39] - The report notes that AI applications are driving significant changes in operational efficiency and commercial opportunities across various sectors, particularly in human resources [39][44] Group 3: Beauty and Personal Care Sector - The beauty and personal care industry is experiencing a mild recovery, with domestic brands showing strong performance during the Double Eleven shopping festival, indicating a shift in competitive dynamics [6][32] - The report identifies key players in the beauty sector, recommending brands like Mao Ge Ping and Shanghai Jahwa, while also suggesting a focus on high-growth segments within the industry [6][32] - The medical beauty sector is under pressure but is seeing consolidation and innovation, with recommendations for companies like Jinbo Biological and Kedi-B [6][32] Group 4: Jewelry and Precious Metals - The jewelry sector is undergoing a transformation, with a focus on overseas expansion as a second growth curve, recommending companies like Laopu Gold and Chaohongji [6][32] - The report emphasizes the importance of high-value jewelry products and the impact of new tax regulations on the market dynamics [6][32] Group 5: Food and Beverage Industry - The food and beverage sector is witnessing a shift, with a focus on leading brands expanding their store counts and product categories, particularly in the tea and dining segments [32][38] - The report highlights the competitive landscape in the restaurant industry, noting the resilience of Western fast food and the growth of Chinese casual dining brands [32][38]

Investment Rating - The report indicates a weak performance in the cosmetics and medical beauty sector, with the Shenwan Beauty Care Index declining by 1.6% from December 5 to December 12, 2025, underperforming the market [3][4]. Core Insights - The cosmetics sector faced pressure in November, with overall GMV in the Taobao system showing weakness due to the pre-promotion of the Double 11 sales event and the rise of Douyin as a sales channel. Brands like Han Shu and Lin Qingxuan maintained stable GMV, while others like Feicui continued to grow significantly [3][9]. - The collagen medical beauty segment is expanding, with two new animal-derived collagen products approved for market entry, expected to drive growth in this area [3][9]. - The report highlights the leading market share of Minoxidil products from Mandi International in the hair loss treatment market, with a steady revenue growth from 982 million yuan in 2022 to approximately 1.455 billion yuan in 2024, reflecting a CAGR of 21.7% from 2022 to 2024 [10][11]. - L'Oréal's acquisition of an additional 10% stake in Galderma, raising its total ownership to 20%, signifies a strategic shift towards the medical beauty and skin health sectors, aiming to adapt to the slowing growth in the Chinese beauty market [3][18]. Summary by Sections Industry Performance - The Shenwan Beauty Care Index and its sub-indices for cosmetics and personal care products have shown declines of 1.2% and 1.7%, respectively, indicating underperformance compared to the Shenwan A Index [4][6]. Key Market Developments - The overall GMV for cosmetics in November was weak, influenced by earlier sales spikes in October and competition from Douyin [9]. - The approval of new collagen products is expected to enhance the supply side of the medical beauty market, with projections for continued expansion in 2026 [9][22]. Company Highlights - Mandi International has maintained a dominant position in the Minoxidil market, with its products accounting for approximately 57% and 71% of the market share in the hair loss treatment and Minoxidil categories, respectively, as of 2024 [11][13]. - The report notes that the Chinese consumer healthcare market is projected to grow from 931.3 billion yuan in 2018 to 16.42 trillion yuan by 2024, with significant growth in hair health and skin health segments [12][13].

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, despite recent underperformance compared to the market [3][4]. Core Insights - The cosmetics and medical beauty sector has shown weaker performance, with the Shenwan Beauty Care Index declining by 1.6% from December 5 to December 12, 2025, underperforming the market [4][5]. - The report highlights that the November sales in the cosmetics sector were impacted by pre-Double 11 promotions and the rise of Douyin as a sales channel, leading to a weaker overall GMV [4][10]. - The collagen medical beauty segment is expanding, with two new animal-sourced collagen products approved for market, indicating growth potential in this area [4][10]. - The report emphasizes the strong market position of Mandi International in the minoxidil hair growth market, with a revenue increase from 982 million yuan in 2022 to approximately 1.455 billion yuan in 2024, reflecting a CAGR of 21.7% [4][11][12]. - L'Oréal's recent acquisition of an additional 10% stake in Galderma signifies a strategic shift towards medical aesthetics and skin health, aiming to adapt to the slowing growth in the Chinese beauty market [4][21]. Summary by Sections Industry Performance - The Shenwan Beauty Care Index decreased by 1.6%, with the Shenwan Cosmetics Index down by 1.2% and the Shenwan Personal Care Index down by 1.7% during the specified period [4][5]. - Notable stock performances included Water Sheep Co. (+5.9%) and Jinsong New Materials (+4.3%), while Hongmian Co. (-10.6%) and Juzhi Biological (-8.4%) faced significant declines [7]. Market Trends - The overall GMV for cosmetics in November was weak, influenced by the earlier sales surge in October and the emergence of Douyin as a competitive sales platform [4][10]. - The report notes that brands like Han Shu and Lin Qingxuan maintained stable GMV, while brands like Feicui continued to experience high growth [4][10]. Company Highlights - Mandi International has established a leading position in the minoxidil market, with a market share of approximately 57% in the hair loss treatment sector and 71% in the minoxidil product market as of 2024 [4][15]. - The company has shown consistent revenue growth, with a net profit increase from 2022 to the first half of 2025, indicating a robust business model [4][12][15]. Investment Recommendations - The report recommends focusing on companies with strong product lines and high profitability in the medical beauty sector, such as Ai Meike, while also suggesting attention to companies like Langzi Co. and Ru Yi Chen [4][10].

Investment Rating - The report does not explicitly state an investment rating for the industry Core Insights - In November, the online apparel and accessories sector experienced a year-on-year growth of 9.1%, with an increase in growth rate compared to October. The average temperature in November was 4.2°C, which is 0.9°C higher than the historical average but 0.9°C lower than last year, indicating robust sales despite lower temperatures [2][11] - The outdoor segment continues to lead the industry with brands like Descente, Kelong, and Aon running year-on-year growth rates of 32.8%, 32.4%, and 21.4% respectively. In the home textile and menswear sectors, brands like Luolai Life and Bosideng saw year-on-year growth of 16.0% and 8.8% respectively [2][11] - The report highlights the approval of two animal collagen products by the National Medical Products Administration, marking significant advancements in concentration, implant materials, and indications [3][13] Industry Data Tracking - In October, apparel retail sales grew by 6.3% year-on-year, with the growth rate improving from September. This was attributed to seasonal promotions and a recovery in offline store traffic due to reduced extreme weather [4][19] - The cosmetics sector also showed resilience, with retail sales increasing by 9.6% year-on-year, reflecting a 11.6 percentage point increase from September [4][29] - The jewelry retail sector continued to recover, with a year-on-year growth of 9.6% in October, supported by rising gold prices and increased regional consumer enthusiasm [4][19] Investment Recommendations - For the apparel sector, Hai Lan Home is recommended for its innovative urban outlet expansion and strong profitability, while Li Ning is expected to see a turning point in 2025 [5][27] - In the beauty and personal care segment, recommendations include Juzi Biological for its strong data resilience and Jinbo Biological for its anticipated new product launches [5][31] - The gold and jewelry sector is recommended for brands with strong market presence, such as Laopu Gold, due to the favorable gold price trends [5][31]

Investment Rating - The investment rating for the retail industry is "Positive" (maintained) [1] Core Insights - The Ministry of Commerce has set a positive tone for the retail industry, emphasizing the importance of quality and service-driven transformation. Retailers with strong supply chain advantages and the ability to adapt are expected to benefit [25][27] - Yonghui Supermarket is undergoing a significant transformation focused on product centralization, with 222 stores modified by the end of September 2025. The company has seen a recovery in same-store sales and is enhancing its product quality and differentiation [27][29] Industry Overview - The retail industry index closed at 2305.32 points, down 0.21% for the week, outperforming the Shanghai Composite Index, which fell 0.34% [5][14] - The supermarket sector showed the highest increase among retail sub-sectors, with a weekly rise of 10.73% [17][20] Investment Recommendations - Focus on high-quality companies in sectors benefiting from emotional consumption themes, including: - **Gold and Jewelry**: Recommend brands like Chow Tai Fook and Chow Hong Kee, which are expected to benefit from differentiated product offerings [6][29] - **Offline Retail**: Highlight companies like Yonghui Supermarket and Ai Ying Shi, which are adapting to market changes [6][29] - **Cosmetics**: Recommend domestic brands that emphasize emotional value and innovative safe ingredients, such as Maogeping and Proya [6][29] - **Medical Aesthetics**: Focus on differentiated product manufacturers and expanding medical chains, recommending companies like Aimeike and Kedi-B [6][29] Company-Specific Insights - **Yonghui Supermarket**: The company reported a revenue of 424.34 billion yuan for the first three quarters of 2025, down 22.2% year-on-year, with a net loss of 7.10 billion yuan. The company is in a transformation phase aimed at quality retail [31][43] - **Chow Tai Fook**: The company achieved a revenue of 389.86 billion HKD for FY2026H1, down 1.1%, with a net profit of 25.34 billion HKD, up 0.1%. The company is optimizing its product structure and store quality [36][38] - **Chow Hong Kee**: The company reported a revenue of 62.37 billion yuan for the first three quarters of 2025, up 28.4%, with a net profit of 3.17 billion yuan, up 0.3%. The company is expanding its franchise model and enhancing product differentiation [39][40]

Core Insights - Shanghai is recognized as a major beauty city in China, with leading cosmetic brands and nearly one-third of the national retail sales of cosmetics coming from the city [1] - The two key districts in Shanghai's cosmetic industry are Fengxian, known for its production capabilities, and Jing'an, which serves as a hub for global cosmetic headquarters and innovation [2][4] Group 1: Industry Overview - Fengxian has established itself as a significant production base, housing nearly 40% of the city's cosmetic companies and is projected to account for 50% of the city's cosmetic output value by 2024 [2] - Jing'an is home to numerous high-profile beauty and skincare companies, including L'Oréal and Perfect Diary, and has launched the "Beauty Innovation Zone" initiative to create a comprehensive beauty economy ecosystem [2][5] Group 2: Collaborative Advantages - The collaboration between Fengxian and Jing'an aims to leverage their respective strengths: Jing'an's innovation and research capabilities with Fengxian's manufacturing prowess [4][7] - Fengxian's production facilities include a range of enterprises from major OEMs to flexible custom manufacturers, while Jing'an boasts top-tier medical resources and innovation centers [4][5] Group 3: Strategic Initiatives - The recent meeting between the two districts focused on developing a coordinated approach to enhance the beauty economy, emphasizing the importance of matching resources and capabilities [3][9] - The proposed model includes a closed-loop mechanism for innovation incubation and industrial transformation, aiming to create a nurturing environment for both emerging and established brands [7][9] Group 4: Market Dynamics - The synergy between the two districts is expected to reduce costs and enhance value across the entire supply chain, allowing companies to focus on core competencies while benefiting from established production capabilities [9][10] - This collaborative approach reflects a broader shift in Shanghai's industrial strategy, moving from competition to cooperation among districts to optimize resource allocation [9][10]

中村直文：时常可以听到"资生堂体现了银座文化，在创始人家族的成员福原义春担任社长时期曾春风 得意"的说法。但实际上，在福原经营的时期资生堂增长乏力。"资生堂的春天"是优先考虑海外市场而 非文化的时期…… 中村直文： 资生堂正在迷失方向。继2024财年（截至2024年12月）之后，该公司发布的2025财年业绩 预期再次出现520亿日元最终亏损，这一数字将创出历史最高纪录。资生堂的股价也下跌至高点的4分之 1以下。资生堂的战略究竟出现了什么问题？ 万亿日元"。 鱼谷雅彦2014年作为没有公司内部董事经验的外部出身者就任资生堂社长 当然增长的动力来自海外市场。资生堂在美国、欧洲、中国等海外设立地区总部，同时录用了来自公司 外部的国际化人才。还开始采用英语召开会议，推进了经营风气改革。 "资生堂体现了银座文化，在创始人家族的成员福原义春担任社长时期曾春风得意"，资生堂内外时常可 以听到这样的声音。确实，资生堂自创立以来一直通过化妆品、食品、建筑物等，作为美文化的体现者 彰显出了较高的存在感。 但实际上，福原参与经营的1980年代后半期至2000年代反而是资生堂增长乏力的时期。30年前的1995年 度销售额约为5400 ...